Deep TMS as a Treatment for Psychiatric Disorders
You’re invited to join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series: Deep TMS as a Treatment for Psychiatric Disorders by speaker Oscar G. Morales, MD.
- Principles of Deep TMS
- Basis of its Use in Psychiatric Disorders
- Review of the Literature for the Use in Depression and Psychiatric Disorders
Format: Webinar using Zoom Video Communications
Cost: Members: $25 | Non-members $50
Speaker: Oscar G. Morales, MD
Dr. Morales is the founder (2009) and medical director of the McLean Hospital TMS Service, the first in the Harvard Medical School and Partners Healthcare system dedicated to psychiatric treatments and investigation. He is responsible for all TMS activities including clinical, training, and current investigation of TMS in treating psychiatric disorders. Dr. Morales is on the faculty of the MGH/McLean Adult Psychiatry Residency Training Program and is involved in the training of Harvard students, residents, fellows, and psychiatrists. Dr. Oscar G. Morales, MD, is Senior Medical Advisor for Achieve TMS, the largest TMS provider in America. He was involved in the efforts that
led Massachusetts Medicare to approve TMS for depression and soon after with the largest private health insurance companies. Dr. Morales pioneered the development of TMS, as a Fellow, he participated in the investigation that led FDA to approve TMS for the treatment of depression (2008) and was the McLean site primary investigator for a worldwide trial that resulted in FDA approval of deep TMS for the treatment of depression (2013). He is an expert in the National Network of Depression Centers (NNDC) TMS Task Group, which develops guidelines, recommendations and collaborative research at a national level. Dr. Morales is Chair of the Brain Stimulation for Anxiety and Depression (BRASFAD) working group of the Depression and Anxiety Division (DAD) at McLean Hospital.